Giving immunotherapy before surgery boosts brain tumor treatment success - News-Medical
Giving immunotherapy before surgery boosts brain tumor treatment success News-Medical
Giving immunotherapy before surgery boosts brain tumor treatment success News-Medical
Investigating Tumor Growth After Immunotherapy Northwestern University
Dr. Duane Mitchell selected to lead UF Health Cancer Institute UF Health
The science behind an ambitious cancer strategy New Scientist
16th Biennial Rivkin Ovarian Cancer Research Symposium Oncodaily
Рак простаты молчит до последнего. Как не пропустить болезнь? / Статья LSM
Внутрипросветная эндоскопическая диагностика: всё о нулевой стадии рака в программе «Здоровая среда» Область 45
A continuing resolution awaiting President Donald Trump’s signature that would avert a government shutdown would also have implications for the federal grantmaking process. The U.S. House of Representatives passed H.R. 6500 on Sept. 1. If signed, the stopgap funding bill will temporarily block proposed changes to the…
Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of Medicine at Mount Sinai. The study, published in Practical Radiation Oncology, is the first to examine the experience of…
B Подмосковье запустили онлайн‑тесты на риски рака Рамблер
Рак прикрывается сахаром: ученые нашли новый механизм защиты опухолей Vesti.az
Adam Dicker: Celebrating a Summer of Progress in Radiation Oncology at Jefferson Oncodaily
With a five-year survival rate of barely 5%, glioblastoma remains one of the deadliest brain cancers. First-line treatment consists of surgery to remove as much tumor tissue as possible.
Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion CNBC